𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of insulin-like growth factor binding proteins in healing tendon lesions

✍ Scribed by Linda A. Dahlgren; Hussni O. Mohammed; Alan J. Nixon

Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
223 KB
Volume
24
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The treatment of overuse tendon injuries with exogenous growth factors such as insulin‐like growth factor‐I (IGF‐I) may facilitate an improved return to sustained athletic function. The biological effects of IGF‐I are exerted under the control of a complex of IGF receptors, binding proteins, and proteases. This IGF system includes a family of six structurally related high‐affinity IGF binding proteins (IGFBPs) that protect IGF‐I from local proteases and restrict access of IGF‐I to its receptor. This study describes the expression of the IGFBPs in flexor tendon after acute injury and during healing over time. Collagenase‐induced lesions were created in the tensile region of the flexor digitorum superficialis tendon of both forelimbs of 14 horses. Tendons were harvested from euthanatized horses 1, 2, 4, 8, or 24 weeks following injury. Gene expression was quantitated by fluorescent real‐time PCR, and protein expression was evaluated by Western ligand blot (WLB). Message for IGFBPs 2 to 6 was expressed in both normal and healing tendon. No IGFBP‐1 mRNA was detected in equine tendon. Message expression for IGFBP‐2, ‐3, and ‐4 increased following injury, whereas message expression for IGFBP‐5 and ‐6 decreased. Protein expression for IGFBP‐2, ‐3, and ‐4 was detected by WLB in normal tendon and showed a marked increase following injury. Protein for IGFBP‐5 and ‐6 was not detectable by WLB in normal or healing tendon. The results of this study document the IGFBP response of flexor tendons to injury and healing, which provides information necessary for the design of protocols that may enhance tendon healing through manipulation of IGF‐I ligand and binding protein levels. © 2005 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res

📜 SIMILAR VOLUMES

Growth factor regulation of insulin-like
Growth factor regulation of insulin-like growth factor binding protein-6 expression in osteoblasts
✍ Bari Gabbitas; Ernesto Canalis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

Previously we have shown that transforming growth factor b (TGF b) 1, basic fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) BB inhibit the synthesis of insulin-like growth factor (IGF) II, but their effects on IGF binding protein (IGFBP)-6 in osteoblast cultures are not kno

Differential gene expression and immunol
Differential gene expression and immunolocalization of insulin-like growth factors and insulin-like growth factor binding proteins between experimental nonunions and standard healing fractures
✍ Akihiro Koh; Takahiro Niikura; Sang Yang Lee; Keisuke Oe; Takaaki Koga; Yoshihir 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 325 KB

## Abstract Insulin‐like growth factors (IGF‐I/II) are important growth factors in bone, and their actions are regulated by six IGF binding proteins (IGFBPs). However, little is known about their exact functions in fracture healing. The aim of this study was to compare the gene expression and immun

Expression of insulin-like growth factor
Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation
✍ Jung H. Y. Park; Mark R. Corkins; Jon A. Vanderhoof; Nia M. Caruso; Marjorie J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

differentiation is linked to growth of Caco-2 cells, with markers of functional differentiation increasing only after the cells stop proliferating (Pinto e t al., 1983). Given these limitations, Caco-2 cells appear to represent the most relevant in vitro model currently available for study of prolif

Hepatic growth hormone receptor, insulin
Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease
✍ R I Holt; P A Crossey; J S Jones; A J Baker; B Portmann; J P Miell 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 1 views

## Major changes in serum levels of insulin-like growth factor After secretion from the anterior pituitary gland, growth hormone (GH) binds to specific cell-surface receptors I (IGF-I) and IGF-binding proteins (IGFBPs) occur in children with end-stage liver disease in association with changes in (

Insulin-like growth factor binding prote
Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasia
✍ Suying Lu; Michael C. Archer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Abstract Insulin‐like growth factor binding protein‐1 (IGFBP‐1) is synthesized in the liver and regulates the mitogenic effects of the insulin‐like growth factors (IGFs). The evidence that IGFBP‐1 plays a role in hepatocarcinogenesis, however, is equivocal. We have, therefore, investigated the d